The Next Wave in Life Sciences: Stephanie Chang interviews Stefan Oelrich, Mar 25, 2021

The level of collaboration between pharma and biotech companies will remain key for overcoming public health challenges in the future. New therapeutics and innovations will play a pivotal role. But what breakthrough technologies are at the forefront of the bio-revolution?

STEFAN OELRICH | Member of the Board of Management and President Pharmaceuticals, Bayer AG In conversation with: STEPHANIE CHANG